New!£29.33 with offer

Cardiogen 20mg

£41.90

Cardiogen is a synthetic tetrapeptide used as a research tool to investigate tissue-specific gene-expression regulation in cardiac-derived experimental systems.

  • OP Labs formerly Oxford Peptides
  • Batch tested Purity: ≥ 98 % (HPLC, typical)
  • CAS Number: N/A
  • Molecular Formula: C18H31N7O9
Volume Pricing
Spend £50+Price £37.71
Spend £150+Price £33.52
Spend £500+Price £29.33

In stock

Free shipping on orders over £20

  • Royal Mail Tracked24
  • Order before 16.00 for same day dispatch
  • Money Back Guarantee
Guaranteed Safe Checkout

secure payment bitcoin visa mastercard bitcoin tron crypto payment

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.

  • OP Labs formerly Oxford Peptides
  • Batch HPLC tested at 99%+ purity
  • Store frozen long term or in fridge when ready to be used
  • Sold for research purposes only
  • Contact us for Wholesale Orders

Download COA here: Cardiogen_20mg.pdf
Please note: if you have a different Batch ID, please contact us for the latest COA.

Cardiogen

Synonyms / Designations: Cardiogen; AEDR; cardiac (heart) peptide bioregulator
Amino Acid Sequence: Ala-Glu-Asp-Arg (AEDR)
CAS Number: N/A
Molecular Formula: C18H31N7O9
Molecular Weight: 489.49 g/mol
Purity: ≥ 99 % (HPLC)
Appearance: White to off-white lyophilised powder
Pack Size: 20 mg (total)
Storage: Desiccated, protected from light, stored at –20 °C or below
Solubility: Soluble in water and buffered aqueous solutions

Description & Mechanism

Cardiogen is a short synthetic tetrapeptide employed as a molecular probe for investigating tissue-specific transcriptional regulation in cardiac-derived cell and tissue systems. It is used experimentally to study modulation of gene-expression programmes in cardiomyocyte and cardiac-fibroblast models, including transcripts associated with contractile proteins, calcium handling and oxidative-stress defence.

Consistent with the Khavinson short-peptide model, Cardiogen is studied as an agent that may translocate intracellularly and engage DNA/chromatin to influence promoter activity. As a low-molecular-weight linear peptide it is used in experimental designs focused on transcriptional regulation and cellular stress signalling; observed effects depend on concentration, model system and exposure conditions.

Applications in Research

  • In-vitro gene-expression studies in cardiomyocyte and cardiac-fibroblast cultures
  • Cellular models of oxidative stress and cardiomyocyte apoptosis / protein synthesis
  • Preclinical models of cardiac aging and ischaemia-related gene-expression changes
  • Probe for short-peptide / chromatin interaction studies

Specifications Summary

ParameterTypical Value / Range
Purity (HPLC)≥ 99 %
AppearanceWhite to off-white lyophilised powder
Molecular Weight489.49 g/mol
Peptide TypeSynthetic linear tetrapeptide bioregulator (Khavinson cytogen family)
SolubilityWater, buffered aqueous solutions
Storage–20 °C, desiccated, dark
Pack Size20 mg (total)

Handling, Reconstitution & Stability

  • Weigh under dry conditions; peptide is hygroscopic
  • Reconstitute in sterile water or appropriate buffered aqueous solution depending on assay requirements
  • Avoid vigorous agitation during dissolution
  • Filter sterilize if required (e.g. 0.22 µm) prior to use
  • Aliquot and store reconstituted solutions at –20 °C or below to minimise degradation
  • Avoid repeated freeze–thaw cycles

Precautions & Notes

  • Experimental behaviour is dependent on concentration, model system and exposure conditions
  • Appropriate experimental controls are recommended
  • Prolonged exposure to light, elevated temperature or aqueous environments may reduce stability
  • Intended strictly for laboratory research use; not for human or veterinary application

References

Khavinson VKh, Linkova NS, Tarnovskaya SI, et al. Short cell-penetrating peptides: a model of interactions with gene promoter sites. Bull Exp Biol Med.
https://pubmed.ncbi.nlm.nih.gov/23484211/

Short Peptides Regulate Gene Expression. Bull Exp Biol Med. 2016.
https://link.springer.com/article/10.1007/s10517-016-3596-7

Khavinson VKh, Popovich IG, et al. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021;26(22):7053.
https://www.mdpi.com/1420-3049/26/22/7053

PubChem Compound Summary, CID 11583989 (Ala-Glu-Asp-Arg).
https://pubchem.ncbi.nlm.nih.gov/compound/11583989

Keywords: Cardiogen, AEDR, cardiac peptide bioregulator, synthetic tetrapeptide